Thermosensitive Liposomen für die regionale Hyperthermie

Literatur

• 1 Bangham A D, Standish M M, Watkins J C. Diffusion of univalent ions across the lamellae of swollen phospholipids.  J Mol Biol. 1965;  13 238-252
• 2 Blackwell K, Vajaskovic Z, Rosen E. et al .A phase I dose-escalation study of liposomal doxorubicin, paclitaxel and hyperthermia in locally advanced breast carcinoma. Meeting abstract, ESHO Munich June 4 - 7
• 3 Cheung A Y, Gannon W E, John M. Thermodynamic therapy for the treatment of cancer,. Meeting abstract, ESHO Munich June 4 - 6, 2003
• 4 Forssen E A, Coulter D M, Proffitt R T. Selective in vivo localisation of daunorubicin small unilamellar vesicles in solid tumours.  Cancer Res. 1992;  52 3255-3261
• 5 Fossheim S L, Il’yasov K A, Hennig J, Bjornerud A. Thermosensitive paramagnetic liposomes for temperature control during MR imaging-guided hyperthermia: in vitro feasibility studies.  Acad Radiol. 2000;  7 1107-1115
• 6 Gaber M H, Hong K, Huang S K, Papahadjopoulos D. Thermosensitive sterically stabilized liposomes: formulation and in vitro studies on mechanism of doxorubicin release by bovine serum and human plasma.  Pharm Res. 1995;  12 1407-1416
• 7 Gaber M H, Wu N Z, Hong K, Huang S K, Dewhirst M W, Papahadjopoulos D. Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks.  Int J Radiat Oncol Biol Phys. 1996;  36 1177-1187
• 8 Gabizon A A. Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy.  Cancer Invest. 2001;  19 424-436
• 9 Gregoriadis G, Neerunjun D E. Control of the rate of hepatic uptake and catabolism of liposome-entrapped proteins injected into rats. Possible therapeutic applications.  Eur J Biochem. 1974;  47 179-185
• 10 Gulati M, Bajad S, Singh S, Ferdous A J, Singh M. Development of liposomal amphotericin B formulation.  J Microencapsul. 1998;  15 137-151
• 11 Hahn G M, Braun J, Har-Kedar I. Thermochemotherapy: synergism between hyperthermia (42 - 43 degrees) and adriamycin (of bleomycin) in mammalian cell inactivation.  Proc Natl Acad Sci USA. 1975;  72 937-940
• 12 Hehr T, Wust P, Bamberg M, Budach W. Current and potential role of thermoradiotherapy for solid tumours.  Onkologie. 2003;  26 295-302
• 13 Hildebrandt B, Wust P, Ahlers O. et al . The cellular and molecular basis of hyperthermia.  Crit Rev Oncol Hematol. 2002;  43 33-56
• 14 Issels R D. Hyperthermia combined with chemotherapy - biological rationale, clinical application, and treatment results.  Onkologie. 1999;  22 374-381
• 15 Jain R K. Delivery of molecules, particles and cells to solid tumours.  Ann Biomed Eng. 1996;  24 457-473
• 16 Kong G, Dewhirst M W. Hyperthermia and liposomes.  Int J Hyperthermia. 1999;  15 345-370
• 17 Kouloulias V E, Dardoufas C E, Kouvaris J R. et al . Liposomal doxorubicin in conjunction with reirradiation and local hyperthermia treatment in recurrent breast cancer: a phase I/II trial.  Clin Cancer Res. 2002;  8 374-382
• 18 Lasic D D, Martin F J, Gabizon A, Huang S K, Papahadjopoulos D. Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times.  Biochim Biophys Acta. 1991;  1070 187-192
• 19 Lindner L H, Dreyling M, Wendtner C M, Sauer H, Hiddemann W, Issels R D. PEG-liposomal doxorubicin, etoposide, ifosfamide and regional hyperthermia (EILA + RHT) in the treatment of high risk soft tissue sarcomas: A phase I/II-study,. Meeting abstract, ESHO Munich June 4 - 7, 2003
• 20 Lopez A M, Wallace L, Dorr R T, Koff M, Hersh E M, Alberts D S. Topical DMSO treatment for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia.  Cancer Chemother Pharmacol. 1999;  44 303-306
• 21 Lyass O, Uziely B, Ben-Yosef R. et al . A Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma.  Cancer. 2000;  89 1037-1047
• 22 Maruyama K, Unezaki S, Takahashi N, Iwatsuru M. Enhanced delivery of doxorubicin to tumor by long-circulating thermosensitive liposomes and local hyperthermia.  Biochim Biophys Acta. 1993;  1149 209-216
• 23 Murray L, Carmichael J. Targeting solid tumours: challanges disappointments and opportunities.  Adv Drug Del Rev. 1995;  17 117-127
• 24 Needham D, Anyarambhatla G, Kong G, Dewhirst M W. A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model.  Cancer Res. 2000;  60 1197-1201
• 25 Needham D, Dewhirst M W. The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors.  Adv Drug Deliv Rev. 2001;  53 285-305
• 26 Schagon O. Liposomen als potenzielle Arzneistoffträger: Variation der biopharmazeutischen Eigenschaften durch 1.2-Dipalmitoyl-sn-glycero-3-phospho-oligo-glycerine. Dissertation, Technische Universität Braunschweig 1996
• 27 Reinl H M, Lindner L H, Schneider P. et al .New thermosensitive liposomes for MR-guided hyperthermia,. Meeting abstract, ISMRM Toronto 2003
• 28 van der Zee J. Heating the patient: a promising approach?.  Ann Oncol. 2002;  13 1173-1184
• 29 Wendtner C M, Abdel-Rahman S, Krych M. et al . Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas.  J Clin Oncol. 2002;  20 3156-3164
• 30 Wust P, Hildebrandt B, Sreenivasa G. et al . Hyperthermia in combined treatment of cancer.  Lancet Oncol. 2002;  3 487-497
• 31 Yatvin M B, Weinstein J N, Dennis W H, Blumenthal R. Design of liposomes for enhanced local release of drugs by hyperthermia.  Science. 1978;  202 1290-1293